Latest Stories
Most recently published stories in Longevity.
Europe Wearable Medical Devices Market Set for Explosive Growth Through 2033. AI-Generated.
The Europe Wearable Medical Devices Market is entering a high-growth phase as technology, healthcare digitization, and chronic disease management converge. According to Renub Research, the market is projected to rise from US$ 11.41 billion in 2024 to US$ 37.4 billion by 2033, expanding at a remarkable CAGR of 14.1% during 2025–2033.
By Renub Research2 months ago in Longevity
Saudi Arabia Generic Drugs Market Size and Forecast 2025–2033. AI-Generated.
The Saudi Arabia Generic Drugs Market is entering a high-growth decade—one shaped by strategic national reforms, local manufacturing expansion, and the increasing awareness of cost-effective therapeutic options. According to Renub Research, the market is projected to grow from US$ 4.05 billion in 2024 to US$ 8.11 billion by 2033, registering a CAGR of 8.02% during the forecast period of 2025–2033.
By Janine Root 2 months ago in Longevity
United States Active Pharmaceutical Ingredients Market Size and Forecast 2025–2033. AI-Generated.
The United States Active Pharmaceutical Ingredients (API) Market is entering a defining decade—one shaped by scientific advancement, a rising chronic disease burden, and an unprecedented surge in demand for both branded and generic medicines. According to Renub Research, the U.S. API market is projected to grow from US$ 67.11 billion in 2024 to US$ 117.86 billion by 2033, registering a CAGR of 6.46% during the 2025–2033 forecast period.
By Janine Root 2 months ago in Longevity
United States Prostate Cancer Biomarkers Market Size & Forecast 2025–2033. AI-Generated.
The United States Prostate Cancer Biomarkers Market is entering a transformative era—one shaped by genomic innovation, precision diagnostics, and increased awareness of personalized healthcare. According to Renub Research, the U.S. market is expected to grow from US$ 1.48 billion in 2024 to US$ 3.54 billion by 2033, advancing at a CAGR of 10.16% throughout 2025–2033.
By Marthan Sir2 months ago in Longevity
United States Nebulizer Market Size & Forecast 2025–2033. AI-Generated.
The United States nebulizer market is entering a period of sustained growth, driven by the relentless rise of respiratory diseases, rapid advancements in aerosol-delivery technology, and a nationwide shift toward home-based healthcare. According to Renub Research, the U.S. nebulizer market is projected to expand from US$ 466.55 million in 2024 to over US$ 730.62 million by 2033, registering a CAGR of 5.11% between 2025 and 2033.
By Marthan Sir2 months ago in Longevity
United States Colon Screening Market Poised for Strong Growth Through 2033. AI-Generated.
The United States Colon Screening Market is entering a pivotal phase of expansion, backed by the nation’s growing emphasis on preventive healthcare. As per Renub Research, the market is expected to surge from US$ 4.95 billion in 2024 to US$ 6.56 billion by 2033, growing at a steady CAGR of 3.18% from 2025 to 2033. This growth trajectory is driven by multiple converging factors—rising colorectal cancer incidence, extensive government-backed screening initiatives, and accelerating improvements in diagnostic technologies.
By Marthan Sir2 months ago in Longevity
United States Ophthalmic Eye Dropper Market Size and Forecast 2025–2033. AI-Generated.
The United States Ophthalmic Eye Dropper Market is entering a decisive growth phase—expanding from US$ 4.58 billion in 2024 to an estimated US$ 7.13 billion by 2033, according to Renub Research. This represents a CAGR of 5.05% from 2025 to 2033, fueled by rising eye disorder cases, sophisticated drug delivery technologies, and a growing shift toward home-based eye care. As digital screen exposure, pollution, and aging-related ocular complications surge across the country, demand for reliable and user-friendly eye droppers is stronger than ever.
By Marthan Sir2 months ago in Longevity
Japan Vitamin K2 Market Size and Forecast 2025–2033. AI-Generated.
The Japanese Market for Vitamin K2 is on a strong upward trajectory, driven by a powerful combination of demographic pressures, rising health awareness, and the country’s thriving functional foods culture. According to Renub Research, the market is projected to grow significantly—from US$ 12.68 million in 2024 to US$ 36.20 million by 2033, registering a robust CAGR of 12.36% between 2025 and 2033. This impressive expansion is rooted in Japan’s unique health challenges and consumer preferences: an aging society, an increasing need for bone and cardiovascular health solutions, and a cultural affinity for natural and fermented ingredients.
By Marthan Sir2 months ago in Longevity
United States Vitamin K2 Market Size & Forecast (2025–2033): A Fast-Rising Nutrient Powering America’s Bone & Heart Health Revolution. AI-Generated.
The United States Vitamin K2 Market is positioned for a dramatic expansion over the next decade. According to Renub Research, the market will surge from US$ 82.84 million in 2024 to US$ 255.46 million by 2033, growing at a strong CAGR of 13.33% (2025–2033). This powerful trajectory reflects a combination of rising consumer health awareness, the shifting landscape of preventive healthcare, the aging U.S. population, and the massive growth of the nation’s dietary supplement and functional food industries.
By jaiklin Fanandish2 months ago in Longevity
United States Intraoperative Imaging Market Size and Forecast (2025–2033). AI-Generated.
The United States Intraoperative Imaging Market is projected to grow from US$ 939.12 million in 2024 to US$ 1,463.14 million by 2033, registering a CAGR of 5.05% during 2025–2033, according to Renub Research. This robust momentum reflects the nation’s increasing shift toward precision-driven, image-guided surgical procedures that enhance accuracy, reduce complications, and elevate patient outcomes.
By jaiklin Fanandish2 months ago in Longevity
United States Tumor Profiling Market Size and Forecast 2025–2033. AI-Generated.
The United States Tumor Profiling Market is entering a transformative era where technology, oncology research, and precision medicine are converging to redefine cancer care. According to Renub Research, the market is expected to reach US$ 7.44 billion by 2033, up from US$ 3.41 billion in 2024, growing at a CAGR of 9.05% from 2025 to 2033. This rapidly expanding sector is being propelled by advanced genomic technologies, the rising burden of cancer across the country, and the accelerating demand for personalized treatment.
By jaiklin Fanandish2 months ago in Longevity
United States Nucleic Acid Methylation Market Size & Forecast 2025–2033. AI-Generated.
The United States Nucleic Acid Methylation Market is weaving a transformative narrative across research laboratories, biotech companies, and clinical diagnostic centers nationwide. Estimated at US$ 906.01 million in 2024, the market is projected to expand significantly to US$ 2,579.85 million by 2033, recording a powerful 12.33% CAGR between 2025 and 2033. This impressive rise is driven by rapid progress in epigenetics research, advanced sequencing technologies, rising cancer burden, and the growing integration of precision medicine across U.S. healthcare systems.
By jaiklin Fanandish2 months ago in Longevity
